The landscape of dementia analysis has advanced drastically with the appearance of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology a long time in advance of indications arise. While these technological developments symbolize impressive development in being familiar with